"Hywin Holdings - WealthBriefing | Global Healthcare Trends Report 2023" Launch Ceremony

In the post-pandemic world, global demand of high-net-worth individuals for healthcare has boomed. 

New health concepts, emerging diagnostic methods, innovative pharmaceuticals, regenerative solutions, gene therapies, and wellness programs have attracted the attention of wealthy clients, their advisors, and investment managers.

Hywin Holdings (NASDAQ: HYW), as a leading provider of wealth management and health management as one integrated proposition, has worked with WealthBriefing in 2023 to interview dozens of scientists, experts, healthcare operators, healthcare investors, and family offices in Asia, Europe and North America, and distill findings into the “Hywin Holdings WealthBriefing | Global Healthcare Trends Report 2023”.

On November 22, Hywin Holdings will host the launch ceremony for this Report, with speeches and panel discussions on

●  The healthcare needs of today's global UHNW families and individuals
●  The solutions being provided by established and emerging healthcare players 
●  The key sectors/ technologies/ business models in healthcare that are attracting investment and capital
●  The interactions between the healthcare requirements/aspirations of the wealthy and their pursuit of ESG goals
 

Programme

Opening Remark
- Mr Andrew Deane
Publisher, WealthBriefingAsia
- Ms Shuming Zhu
Member of Board of Director, Hywin Holdings (NASDAQ: HYW)

Presentation of "Hywin Holdings - WealthBriefing | Global Healthcare Trends Report 2023"
- Mr Lawrence Lok
Chief Financial Officer, Hywin Holdings (NASDAQ: HYW)

Keynote Speech
- Ms Jing Qian
Chief Health Officer, Hywin Health
                                                                                        
First Round of Panel Discussion 
Moderator:
- Mr Andrew Deane
Publisher, WealthBriefingAsia
Panelists:
- Ms Theodora Viney
Head of Marketing, ClearView Financial Media
- Mr Lawrence Lok
Chief Financial Officer, Hywin Holdings (NASDAQ: HYW)
- Dr Clark Cheng
Head of Operation, Humansa
- Ms Pamela Hsu Phua
Chief Executive Officer Asia, VP Bank AG
- Ms Gopi Mirchandani
Head of North Asia, Schroders

Second Round of Panel Discussion 
Moderator:
- Ms Jing Qian
Chief Health Officer, Hywin Health
Panelists:
- Mr Michael Sun
Head of Healthcare and Bioscience Investment Banking, Bank of China International
- Mr Arwen Liu
Senior Portfolio Manager, Sectoral Asset Management
- Mr Will Wang
Head of Client Solutions & Strategic Partnerships Asia, VP Bank AG
- Ms Diana Dai
Investment Director & General Manager of Beijing Office, Schroders
- Mr Michael Bai
Lead of Greater China Investor Relations, Carlyle 

Cocktail Reception 

Partner: